Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial - Murphy, J E; Wo, J Y; Ryan, D P (JAMA Oncol, 2018)
et al.